Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,698.15
+63.35 (1.12%)
At close: Apr 21, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 681.1 billion as of April 22, 2026. Its market cap has increased by 13.86% in one year.
Market Cap
681.10B
Enterprise Value
657.79B
Revenue
142.53B
Ranking
n/a
PE Ratio
28.72
Stock Price
5,698.15
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 681.10B, an increase of 312.28%. That is a compound annual growth rate of 14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 674.59B | 2.46% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.41T |
| Lupin | 1.06T |
| Dr. Reddy's Laboratories | 1.03T |
| Abbott India | 548.17B |
| GlaxoSmithKline Pharmaceuticals | 415.35B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |